Correlation Between BioAffinity Technologies and Syneos Health

Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies and Syneos Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies and Syneos Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between bioAffinity Technologies Warrant and Syneos Health, you can compare the effects of market volatilities on BioAffinity Technologies and Syneos Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies with a short position of Syneos Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies and Syneos Health.

Diversification Opportunities for BioAffinity Technologies and Syneos Health

-0.48

Correlation Coefficient

BioAffinity Technologies  Syneos Health

Very good diversification

The 3 months correlation between BioAffinity and Syneos is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies Warra and Syneos Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syneos Health and BioAffinity Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies Warrant are associated (or correlated) with Syneos Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syneos Health has no effect on the direction of BioAffinity Technologies i.e., BioAffinity Technologies and Syneos Health go up and down completely randomly.

Pair Corralation between BioAffinity Technologies and Syneos Health

If you would invest  117.00  in bioAffinity Technologies Warrant on September 1, 2024 and sell it today you would lose (45.00) from holding bioAffinity Technologies Warrant or give up 38.46% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	1.67%
Values	Daily Returns

bioAffinity Technologies Warra  vs.  Syneos Health

BioAffinity Technologies

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in bioAffinity Technologies Warrant are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, BioAffinity Technologies showed solid returns over the last few months and may actually be approaching a breakup point.

Syneos Health

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Syneos Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Syneos Health is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with BioAffinity Technologies and Syneos Health

The main advantage of trading using opposite BioAffinity Technologies and Syneos Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies position performs unexpectedly, Syneos Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syneos Health will offset losses from the drop in Syneos Health's long position.

The idea behind bioAffinity Technologies Warrant and Syneos Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.